Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of JCOG1302A

被引：0

作者：

Sato, Y. ^{[1
]}

Mizusawa, J. ^{[1
]}

Nakamura, K. ^{[1
]}

Fukagawa, T. ^{[2
]}

Katai, H. ^{[3
]}

Haruta, S. ^{[4
]}

Yamada, M. ^{[5
]}

Takagi, M. ^{[6
]}

Tamura, S. ^{[7
]}

Yoshimura, T. ^{[8
]}

Inada, T. ^{[9
]}

Hirabayashi, N. ^{[10
]}

Wada, I. ^{[11
]}

Kodera, Y. ^{[12
]}

Tokunaga, M. ^{[13
]}

Yoshikawa, T. ^{[3
]}

Boku, N. ^{[14
]}

Sano, T. ^{[15
]}

Sasako, M. ^{[16
]}

Terashima, M. ^{[17
]}

机构：

[1] Natl Canc Ctr, Operat Off, JCOG Data Ctr, Tokyo, Japan

[2] Teikyo Univ Hosp, Dept Surg, Tokyo, Japan

[3] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan

[4] Toranomon Gen Hosp, Dept Gastroenterol Surg, Tokyo, Japan

[5] Gifu Municipal Hosp, Dept Surg, Gifu, Japan

[6] Shizuoka Prefectural Gen Hosp, Dept Gastroenterol Surg, Shizuoka, Japan

[7] Yao Municipal Hosp, Surg Div, Osaka, Japan

[8] Tenri Hosp, Dept Digest Surg, Nara, Japan

[9] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan

[10] Hiroshima City Asa Hosp, Dept Surg, Hiroshima, Japan

[11] Tokyo Metropolitan Bokutoh Hosp, Dept Surg, Tokyo, Japan

[12] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg, Nagoya, Aichi, Japan

[13] Natl Canc Ctr Hosp East, Gastr Surg Div, Chiba, Japan

[14] Natl Canc Ctr, Gastrointesitnal Med Oncl, Tokyo, Japan

[15] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan

[16] Yodogawa Chrisitan Hosp, Dept Surg, Osaka, Hyogo, Japan

[17] Shizuoka Canc Ctr, Dept Gastr Surg, Shizuoka, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

656P

引用

页数：2

共 50 条

[41] Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma
Fernandez, Eugenio
Cacheux, Wulfran
Frossard, Jean-Louis
Koessler, Thibaud
Abou, Magali
Moniez, Michael
Huber, Olivier
Puppa, Giacomo
Roth, Arnaud
DIGESTIVE AND LIVER DISEASE, 2017, 49 (05) : 552 - 556
[42] The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113
Ikuhiro Yamada
Chigusa Morizane
Takuji Okusaka
Junki Mizusawa
Tomoko Kataoka
Makoto Ueno
Masafumi Ikeda
Naohiro Okano
Akiko Todaka
Satoshi Shimizu
Nobumasa Mizuno
Mitsugu Sekimoto
Kazutoshi Tobimatsu
Hironori Yamaguchi
Tomohiro Nishina
Hirofumi Shirakawa
Yasushi Kojima
Takamasa Oono
Yasuyuki Kawamoto
Masayuki Furukawa
Tomohisa Iwai
Kentaro Sudo
Keiya Okamura
Tatsuya Yamashita
Naoya Kato
Kazuhiko Shioji
Kyouko Shimizu
Toshio Nakagohri
Ken Kamata
Hiroshi Ishii
Junji Furuse
Scientific Reports, 12
[43] EARLY GASTRIC-CANCER - ENDOSCOPIC DIAGNOSIS OF DEPTH OF INVASION
SANO, T
OKUYAMA, Y
KOBORI, O
SHIMIZU, T
MORIOKA, Y
DIGESTIVE DISEASES AND SCIENCES, 1990, 35 (11) : 1340 - 1344
[44] The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113
Yamada, Ikuhiro
Morizane, Chigusa
Okusaka, Takuji
Mizusawa, Junki
Kataoka, Tomoko
Ueno, Makoto
Ikeda, Masafumi
Okano, Naohiro
Todaka, Akiko
Shimizu, Satoshi
Mizuno, Nobumasa
Sekimoto, Mitsugu
Tobimatsu, Kazutoshi
Yamaguchi, Hironori
Nishina, Tomohiro
Shirakawa, Hirofumi
Kojima, Yasushi
Oono, Takamasa
Kawamoto, Yasuyuki
Furukawa, Masayuki
Iwai, Tomohisa
Sudo, Kentaro
Okamura, Keiya
Yamashita, Tatsuya
Kato, Naoya
Shioji, Kazuhiko
Shimizu, Kyouko
Nakagohri, Toshio
Kamata, Ken
Ishii, Hiroshi
Furuse, Junji
SCIENTIFIC REPORTS, 2022, 12 (01)
[45] Response evaluation after neoadjuvant chemotherapy for resectable gastric cancer: Downsizing vs downstaging
Sando, A.
Bringeland, E.
Gronbech, J.
Dai, H.
Fougner, R.
ANNALS OF ONCOLOGY, 2022, 33 : S361 - S361
[46] An evaluation of adjuvant chemotherapy following neoadjuvant chemotherapy and resection for borderline resectable and locally advanced pancreatic cancer
Zhang, Chunmeng
Wu, Ruiqian
Smith, Lynette M.
Baine, Michael
Lin, Chi
Reames, Bradley N.
AMERICAN JOURNAL OF SURGERY, 2022, 224 (01): : 51 - 57
[47] Neoadjuvant chemotherapy (CT) and postoperative chemoradiation (PCRT) in locally advanced, resectable, gastric cancer (LAGC). Preliminary results of a pilot study
Buonadonna, A.
De Paoli, A.
Sigon, R.
Cannizzaro, R.
Canzonieri, V.
Boz, G.
Innocente, R.
Rossi, C.
De Marchi, F.
Frustaci, S.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[48] Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer
Hayata, Keiji
Ojima, Toshiyasu
Nakamori, Mikihito
Nakamura, Masaki
Katsuda, Masahiro
Kitadani, Junya
Takeuchi, Akihiro
Tabata, Hirotaka
Maruoka, Shinpei
Yamaue, Hiroki
ANTICANCER RESEARCH, 2018, 38 (09) : 5267 - 5273
[49] Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113
Okano, Naohiro
Morizane, Chigusa
Okusaka, Takuji
Sadachi, Ryo
Kataoka, Tomoko
Kobayashi, Satoshi
Ikeda, Masafumi
Ozaka, Masato
Mizutani, Tomonori
Sugimori, Kazuya
Todaka, Akiko
Shimizu, Satoshi
Mizuno, Nobumasa
Yamamoto, Tomohisa
Sano, Keiji
Tobimatsu, Kazutoshi
Katanuma, Akio
Gotoh, Kunihito
Yamaguchi, Hironori
Ishii, Hiroshi
Ohba, Akihiro
Furuse, Junji
Ueno, Makoto
ONCOLOGIST, 2024, 29 (01): : e97 - e107
[50] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer Reply
Kang, Yoon-Koo
Kim, Hyung-Don
Ryu, Min-Hee
Noh, Sung Hoon
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (34) : 3884 - 3886

← 1 2 3 4 5 →